153 related articles for article (PubMed ID: 36209449)
21. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
22. Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study.
Tracey E; Hacker NF; Young J; Armstrong BK
Int J Gynecol Cancer; 2014 Sep; 24(7):1232-40. PubMed ID: 25153678
[TBL] [Abstract][Full Text] [Related]
23. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: A population-based cohort study in Taiwan.
Ding DC; Chen W; Wang JH; Lin SZ
Medicine (Baltimore); 2018 Sep; 97(39):e12608. PubMed ID: 30278576
[TBL] [Abstract][Full Text] [Related]
24. Cervical, endometrial and ovarian cancers among immigrants in Sweden: importance of age at migration and duration of residence.
Beiki O; Allebeck P; Nordqvist T; Moradi T
Eur J Cancer; 2009 Jan; 45(1):107-18. PubMed ID: 18829301
[TBL] [Abstract][Full Text] [Related]
25. Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study.
Grandi G; Perrone AM; Chiossi G; Friso S; Toss A; Sammarini M; Facchinetti F; Botticelli L; Palma F; De Iaco P
Gynecol Oncol; 2019 Jul; 154(1):163-168. PubMed ID: 31104904
[TBL] [Abstract][Full Text] [Related]
26. Strategies for Lynch syndrome identification in selected and unselected gynecological cancers.
Carnevali I; Sahnane N; Chiaravalli AM; Di Lauro E; Facco C; Facchi S; Casarin J; Ghezzi F; Sessa F; Tibiletti MG
Eur J Cancer Prev; 2022 Jul; 31(4):369-376. PubMed ID: 34519692
[TBL] [Abstract][Full Text] [Related]
27. Serum endocan levels in endometrial and ovarian cancers.
Laloglu E; Kumtepe Y; Aksoy H; Topdagi Yilmaz EP
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27734523
[TBL] [Abstract][Full Text] [Related]
28. Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
Jareid M; Thalabard JC; Aarflot M; Bøvelstad HM; Lund E; Braaten T
Gynecol Oncol; 2018 Apr; 149(1):127-132. PubMed ID: 29482839
[TBL] [Abstract][Full Text] [Related]
29. Reduced risk of breast, endometrial and ovarian cancer in women with celiac disease.
Ludvigsson JF; West J; Ekbom A; Stephansson O
Int J Cancer; 2012 Aug; 131(3):E244-50. PubMed ID: 21953605
[TBL] [Abstract][Full Text] [Related]
30. Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study.
Burghaus S; Häberle L; Schrauder MG; Heusinger K; Thiel FC; Hein A; Wachter D; Strehl J; Hartmann A; Ekici AB; Renner SP; Beckmann MW; Fasching PA
BMC Cancer; 2015 Oct; 15():751. PubMed ID: 26487094
[TBL] [Abstract][Full Text] [Related]
31. Oral contraceptives and breast, endometrial, and ovarian cancers. The Cancer and Steroid Hormone Study Group, Atlanta Georgia.
Gwinn ML
J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S83-7. PubMed ID: 12268773
[TBL] [Abstract][Full Text] [Related]
32. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Lu KH; Dinh M; Kohlmann W; Watson P; Green J; Syngal S; Bandipalliam P; Chen LM; Allen B; Conrad P; Terdiman J; Sun C; Daniels M; Burke T; Gershenson DM; Lynch H; Lynch P; Broaddus RR
Obstet Gynecol; 2005 Mar; 105(3):569-74. PubMed ID: 15738026
[TBL] [Abstract][Full Text] [Related]
33. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
[TBL] [Abstract][Full Text] [Related]
34. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
[TBL] [Abstract][Full Text] [Related]
35. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.
Hemminki K; Aaltonen L; Li X
Cancer; 2003 May; 97(10):2432-9. PubMed ID: 12733142
[TBL] [Abstract][Full Text] [Related]
36. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
Schoen RE; Weissfeld JL; Kuller LH
Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
[TBL] [Abstract][Full Text] [Related]
37. Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review.
Lim N; Hickey M; Young GP; Macrae FA; Kelly C
Int J Gynecol Cancer; 2022 May; 32(5):646-655. PubMed ID: 35437274
[TBL] [Abstract][Full Text] [Related]
38. Acceptability of quality indicators for the management of endometrial, cervical and ovarian cancer: results of an online survey.
Luyckx A; Wyckmans L; Bonte AS; Trinh XB; van Dam PA
BMC Womens Health; 2020 Jul; 20(1):151. PubMed ID: 32703282
[TBL] [Abstract][Full Text] [Related]
39. A prospective study on dietary acrylamide intake and the risk for breast, endometrial, and ovarian cancers.
Wilson KM; Mucci LA; Rosner BA; Willett WC
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2503-15. PubMed ID: 20693310
[TBL] [Abstract][Full Text] [Related]
40. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
